Sort:
Open Access Full Length Article Issue
Bcl6 controls the stability and suppressive function of regulatory T cells in head and neck squamous cell carcinoma
Genes & Diseases 2025, 12(4): 101505
Published: 26 December 2024
Abstract PDF (3.9 MB) Collect
Downloads:1

Head and neck squamous cell carcinoma (HNSCC) ranks as the sixth most common cancer globally. Most studies in HNSCC demonstrated that regulatory T (Treg) cells confine the anti-tumor activity of effector T cells which may contribute to the immune escape and uncontrolled tumor progression. Here, we uncovered that the specific abrogation of Bcl6 in Treg cells resulted in significantly delayed malignant transformation of 4NQO-induced tumorigenesis. Bcl6 deficiency impairs the lineage stability of Treg cells by down-regulating the histone H3K4 trimethylation. Importantly, Bcl6 inhibition repressed the tumor growth of murine HNSCC and exhibited synergistic effects with immune checkpoint blockade therapy. These findings suggest that Bcl6 can be exploited as a promising therapeutic target for HNSCC treatment.

Open Access Original Article Issue
Anatomical hepatectomy for achieving textbook outcome for perihilar cholangiocarcinoma treated with curative-intent resection: A multicenter study
iLIVER 2022, 1(4): 245-251
Published: 13 November 2022
Abstract PDF (674.2 KB) Collect
Downloads:42
Background and aim

The textbook outcome (TO) is a comprehensive measure that is superior to individual measures for analysis of surgical quality of care. Anatomical hepatectomy (AH) is beneficial in terms of short-term outcomes in patients undergoing resection. This study was performed to investigate the association between AH and achieving the TO for patients with perihilar cholangiocarcinoma (pCCA) treated with curative-intent resection.

Methods

This study involved patients who underwent curative-intent resection for newly diagnosed pCCA from January 2013 to January 2018 at three hospitals in China. All patients were divided into two groups according to the type of hepatectomy: the AH group and non-AH group. The incidence and distribution of achieving the TO were compared between the two groups. Univariable and multivariable logistic regression analyses were used to identify independently predictive factors associated with achieving the TO in patients with pCCA.

Results

In total, 333 patients were enrolled [AH group, 225 (67.6%); non-AH group, 108 (32.4%)]. The incidence of achieving the TO in all patients was 24.3%, and the incidence was significantly higher in the AH than non-AH group (30.7% vs. 11.1%, respectively). Multivariable analysis revealed that AH, total bilirubin concentration of < 34 μmol/L, maximum tumor size of < 3 cm, no macrovascular invasion, and no lymph node metastasis were independently associated with a higher incidence of achieving the TO.

Conclusions

The TO was achieved in approximately one-fourth of patients with pCCA who underwent curative-intent resection. The use of AH was more conducive to achieving the TO in patients with pCCA.

Total 2